82 related articles for article (PubMed ID: 25687)
1. Inhibition of [3H]-dihydroalprenolol binding to rat cardiac membranes of various beta-blocking agents.
Chenieux-Guicheney P; Dausse JP; Meyer P; Schmitt H
Br J Pharmacol; 1978 May; 63(1):177-81. PubMed ID: 25687
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding.
Williams LT; Jarett L; Lefkowitz RJ
J Biol Chem; 1976 May; 251(10):3096-104. PubMed ID: 942608
[TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
Chang RS; Lotti VJ
Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line.
Mauger JP; Worcel M
Br J Pharmacol; 1980 Apr; 68(4):731-9. PubMed ID: 6103725
[TBL] [Abstract][Full Text] [Related]
5. Identification of beta adrenergic receptors in rat hypothalamus.
Caron MG; Gagne B; De Lean A
Can J Biochem; 1977 Jul; 55(7):693-9. PubMed ID: 19139
[TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
Sawutz DG; Sylvestre D; Homcy CJ
J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
[TBL] [Abstract][Full Text] [Related]
7. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
[TBL] [Abstract][Full Text] [Related]
8. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.
Zatz M; Kebabian JW; Romero JA; Lefkowitz RJ; Axelrod J
J Pharmacol Exp Ther; 1976 Mar; 196(3):714-22. PubMed ID: 4608
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
Riva MA; Creese I
Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.
Sandnes D; Westergren T; Sand TE; Sager G; Refsnes M; Christoffersen T; Jacobsen S
Acta Pharmacol Toxicol (Copenh); 1984 Oct; 55(4):287-96. PubMed ID: 6150600
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of lipolytic activities in the genetically obese Zucker fatty rats--experimental study on (-)-[3H]dihydroalprenolol binding in the intact fat cells].
Matsumoto G
Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1145-59. PubMed ID: 6141076
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characteristics of beta-adrenoceptor binding sites in intact and sympathectomized rat spleen.
Nahorski SR; Barnett DB; Howlett DR; Rugg EL
Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 307(3):227-33. PubMed ID: 226895
[TBL] [Abstract][Full Text] [Related]
13. Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes.
Caron MG; Lefkowitz RJ
J Biol Chem; 1976 Apr; 251(8):2374-84. PubMed ID: 4447
[TBL] [Abstract][Full Text] [Related]
14. Identification of beta-adrenoceptors in bovine teat muscles by 3H-dihydroalprenolol binding.
Roets E; Peeters G; Leysen JE
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):203-14. PubMed ID: 6091578
[TBL] [Abstract][Full Text] [Related]
15. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
Williams LT; Gore TB; Lefkowitz RJ
J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
[TBL] [Abstract][Full Text] [Related]
16. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
Lang PH; Lemmer B
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
[TBL] [Abstract][Full Text] [Related]
17. Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.
Alexander RW; Williams LT; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1564-8. PubMed ID: 1055427
[TBL] [Abstract][Full Text] [Related]
18. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species.
Nahorski SR
Eur J Pharmacol; 1978 Oct; 51(3):199-209. PubMed ID: 213289
[TBL] [Abstract][Full Text] [Related]
20. The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (-)-[3H]dihydroalprenolol binding to cardiac and lung membranes.
Baker SP; Posner P
Life Sci; 1983 Aug; 33(5):459-66. PubMed ID: 6135967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
